摘要
目的探讨宫缩乏力性产后出血临床治疗中卡前列素氨丁三醇的应用效果。方法选择本院于2018年3月—12月期间收治的宫缩乏力性产后出血患者70例,遵循随机数字表,以计算机为工具,将患者划分为研究组(35例患者)与参照组(35例患者),参照组患者接受缩宫素治疗,研究组患者被施以卡前列素氨丁三醇治疗,比对两组患者产后2 h出血量、产后24 h出血量以及并发症发生率。结果研究组患者产后2 h出血量与产后24 h出血量均低于参照组患者,差异有统计学意义(t值分别为13.485,22.240,P<0.05);研究组患者的并发症发生率为8.57%,低于参照组患者的28.57%,两组数据组间差异有统计学意义(χ^2值为4.629,P<0.05)。结论宫缩乏力性产后出血患者被施以卡前列素氨丁三醇治疗,不仅可以减少患者出血量,还能降低患者出现并发症的风险,效果确切,安全可靠。
Objective To investigate the application effect of carprostol tromethamine in clinical treatment of postpartum hemorrhage due to uterine weakness.Methods Seventy patients with uterine weakness and postpartum hemorrhage who were admitted to the hospital from March 2018 to December 2018 were enrolled.The patients were divided into the study group(35 patients)and the reference group(35 patients)with a computerized tool according to a random number table.,the reference group was received oxytocin treatment,the study group was treated with carprostol tromethamine,comparing the postpartum 2 h bleeding volume,24 h postpartum hemorrhage and complications rate.Results The 2 h postpartum hemorrhage volume and postpartum 24 h hemorrhage volume in the study group were lower than those in the reference group,the difference between the groups was statistically significant(t values were 13.485,22.240,P<0.05).The complication rate of the study group was 8.57%,which was lower than 28.57%of the patients in the reference group.The difference between the two groups was statistically significant(χ^2 value was 4.629,P<0.05).Conclusion The treatment of patients with postpartum hemorrhage due to uterine atony is treated with carprostol tromethamine,which can not only reduce the amount of bleeding,but also reduce the risk of complications.The effect is clear,safe and reliable.
作者
邢芝兰
XING Zhilan(Department of Secondary Obstetrics,Lingchen District People's Hospital of Dezhou City,Dezhou Shandong 253500,China)
出处
《中国继续医学教育》
2019年第27期127-128,共2页
China Continuing Medical Education
关键词
宫缩乏力
产后出血
卡前列素氨丁三醇
产后出血量
效果观察
并发症发生率
uterine weakness
postpartum hemorrhage
carprostol tromethamine
postpartum hemorrhage
effect observation
complication rate
